Select a Region

North America

Newscenter

Your hub for company news and information

EVERSANA

Posted on April 27, 20224/27/22

EVERSANA Announces European Expansion with New Location in the United Kingdom

Posted on April 14, 20224/14/22

EVERSANA and UpScriptHealth Announce Integrated, Direct-to-Patient Platform, Transforming the Patient Journey to Accelerate Therapy Access, Affordability and Adherence

Posted on March 22, 20223/22/22

EVERSANA’s Data & Analytics Platform ACTICS by EVERSANA Named a 2022 Artificial Intelligence Award Winner

Posted on March 17, 20223/17/22

EVERSANA unveils global price and market access solution NAVLIN by EVERSANA

EVERSANA

Posted on February 28, 20222/28/22

Rare Disease Day 2022: A Message from EVERSANA CEO Jim Lang

EVERSANA

Posted on February 23, 20222/23/22

EVERSANA™ MANAGEMENT CONSULTING Named a Best Boutique Consulting Firm by Vault

Posted on February 16, 20222/16/22

THREAD and EVERSANA Announce Industry’s First Integrated, Decentralized Registry and Real-World Data (RWD)-Driven Evidence and Commercialization Solution

Posted on February 3, 20222/3/22

EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World Evidence & Technology Platforms

EVERSANA

Posted on February 2, 20222/2/22

EVERSANA Agencies Win Multiple 2021 PM360 Pharma Choice Awards

Posted on February 2, 20222/2/22

Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI